You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 5, May 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

MYC Amplification in Squamous Cell Carcinomas of the Head and Neck

Juan P. Rodrigo, MD; Pedro S. Lazo, PhD; Sofía Ramos, PhD; Ignacio Alvarez, MD; Carlos Suárez, MD

Arch Otolaryngol Head Neck Surg. 1996;122(5):504-507.


Abstract

Objectives
To establish the frequency of MYC amplification in squamous cell carcinoma (SCC) of the head and neck and to evaluate its correlation with clinicopathologic variables that are used in clinical practice.

Design
Cohort analytic study.

Setting
University hospital.

Patients
Fifty-nine consecutive patients with SCC of the head and neck.

Intervention
Oncologic surgery.

Main Outcome Measures
The MYC copy number in tumor samples was estimated with the polymerase chain reaction. The presence or absence of amplification was correlated with the anatomic site, T stage, nodal involvement, pathologic grade, recurrence, distant metastases, and survival.

Results
Six SCC specimens (11%) showed MYC amplification. A highly statistical correlation between MYC amplification and T stage was noted (P<.005). Amplification was also significantly correlated with a hypopharyngeal primary site (P<.05). No correlation among amplification status, nodal involvement, pathologic grade, relapse, metastases, and survival was observed.

Conclusions
Amplification of MYC is associated with advanced primary tumors, and it appears to be a late event in the tumorigenesis of SCCS of the head and neck. However, there is no correlation between MYC amplification and prognosis.

(Arch Otolaryngol Head Neck Surg. 1996;122:504-507)



Author Affiliations

From the Otorhinolaryngology Service, Hospital Central de Asturias (Drs Rodrigo, Alvarez, and Suárez), and the Department of Biochemistry and Molecular Biology (Drs Lazo and Ramos), Universidad de Oviedo, Oviedo, Spain.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Epidermal Growth Factor Receptor Biology in Head and Neck Cancer
Kalyankrishna and Grandis
JCO 2006;24:2666-2672.
ABSTRACT | FULL TEXT  

The Loss of PIN1 Deregulates Cyclin E and Sensitizes Mouse Embryo Fibroblasts to Genomic Instability
Yeh et al.
J. Biol. Chem. 2006;281:241-251.
ABSTRACT | FULL TEXT  

Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck
Ginos et al.
Cancer Res. 2004;64:55-63.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.